Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZBT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation, due for completion by December 22, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
SKYRIZI is a biologic medication used in the treatment of inflammatory skin conditions and is being procured through DLA's medical supply chain to support Defense Health Agency and other federal healthcare systems. AmerisourceBergen's role as a pharmaceutical prime vendor reflects its significant capability to fulfill federal medical procurement requirements across a broad spectrum of therapeutic domains, from specialty biologics to generic medications. The award demonstrates the contractor's continued participation in the DLA's pharmaceutical distribution network, which serves military personnel, veterans, and other federal healthcare beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DR26F4ZBT?
SPE2DR26F4ZBT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F4ZBT worth?
The government has obligated $12,467 on SPE2DR26F4ZBT.
Is contract SPE2DR26F4ZBT an order under another contract?
Yes. SPE2DR26F4ZBT is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZBT competed?
The extent of competition for SPE2DR26F4ZBT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award